Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals.

Tommaso-Francesco AielloPedro Puerta-AlcaldeMariana ChumbitaCarlos LoperaPatricia MonzóAlbert CortesFrancesc Fernández-AvilésMaría Suárez-LledóJuan CorreaValentín Ortiz-Maldonado Genoveva CuestaNuria Martinez-CibrianJordi EsteveMaria Ángeles MarcosJosep MensaAlex SorianoCarolina Garcia-Vidalnull null

Published in: The Journal of antimicrobial chemotherapy (2023)

Current outcomes of high-risk patients with haematological malignancies hospitalized with COVID-19 during Omicron variant predminance are good with the use of early antiviral strategies. Persistent viral shedding is uncommon.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
insulin resistance
adipose tissue
type diabetes
skeletal muscle